
rajinder
2h
Breaking at #ESCCongress2025: DIGIT-HF shows digitoxin, added to standard care in advanced HFrEF, cuts the combined risk of death or HF hospitalization (HR 0.82; p=0.03). May be a viable add-on—especially for patients with AF, low BP, high HR, or renal issues. https://www.escardio.org/The-ESC/Press-Office/Press-releases/Digitoxin-improves-outcomes-in-advanced-heart-failure